Poulsen K, Hjorth J P, Kilian M
Department of Oral Biology, Royal Dental College, University of Aarhus, Denmark.
Infect Immun. 1988 Apr;56(4):987-92. doi: 10.1128/iai.56.4.987-992.1988.
Immunoglobulin A1 (IgA1) proteases are thought to be important virulence factors in certain bacterial infections, including meningitis, and may have potential usage in vaccines. In this study, we compared the locations of EcoRI, BamHI, and PstI restriction endonuclease sites in the IgA1 protease gene (iga) region of whole-cell DNA from 76 Haemophilus influenzae strains. The analysis was performed by using isolated fragments of the cloned iga gene, which encodes the IgA1 protease originating from a H. influenzae serotype d strain, as probes in Southern blot experiments. All strains, including three without detectable IgA1 protease activity, had DNA sequences with a high degree of homology to the iga probes. The numbers and sizes of the DNA fragments hybridizing with the probes indicated that only three strains, none of which was of serotype b, had more than one iga gene. The iga restriction fragment length patterns of 60 clinical isolates of serotype b were of only four distinct types, which correlated with previously observed clusters of multilocus genotypes (electrophoretic types). This correlation supports the concept of the clonal population structure of H. influenzae. Three of the iga gene restriction types, which appear to represent 98% of the H. influenzae serotype b population, encode IgA1 proteases that were inhibited by antisera to any one of these types and therefore could form the basis for the development of a vaccine against H. influenzae meningitis.
免疫球蛋白A1(IgA1)蛋白酶被认为是包括脑膜炎在内的某些细菌感染中的重要毒力因子,并且可能在疫苗中有潜在用途。在本研究中,我们比较了76株流感嗜血杆菌全细胞DNA的IgA1蛋白酶基因(iga)区域中EcoRI、BamHI和PstI限制性内切酶位点的位置。分析是通过使用克隆的iga基因的分离片段进行的,该基因编码源自一株d型流感嗜血杆菌的IgA1蛋白酶,作为Southern印迹实验中的探针。所有菌株,包括三株未检测到IgA1蛋白酶活性的菌株,其DNA序列与iga探针具有高度同源性。与探针杂交的DNA片段的数量和大小表明,只有三株菌株(均非b型血清型)具有不止一个iga基因。60株b型血清型临床分离株的iga限制性片段长度模式仅为四种不同类型,这与先前观察到的多位点基因型(电泳型)簇相关。这种相关性支持了流感嗜血杆菌克隆群体结构的概念。iga基因限制性类型中的三种,似乎代表了98%的流感嗜血杆菌b型血清型群体,编码的IgA1蛋白酶可被针对这些类型中任何一种的抗血清抑制,因此可为开发抗流感嗜血杆菌脑膜炎疫苗奠定基础。